All filters
Abstracts
Comparative analysis of hepatitis B virus serologic profiles and biochemical markers with viral loads in Ondo, Nigeria.
M. Odimayo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Viral hepatitis B and C seroprevalence among at risk population in Taraba state: a seroprevalence study
A. Lamiya
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of viral hepatitis among health care workers (HCWS) in Taraba state, Nigeria
O. Tiwah John
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of hepatitis B surface antigen (HBsAG) and hepatitis C antibodies (HCVAb) among hemodialysis patients at the Yaounde General Hospital, Cameroon.
R. Kamga Wouambo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
High seroprevalence of viral hepatitis among animal handlers in Abeokuta, Nigeria
A. Oluremi
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Sustainability of immune response to hepatitis B virus vaccination three years after vaccination among HIV-1 infected and uninfected adults in Kenya
R. Kamoni
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Achieving sustained viral response (SVR) – is it a motivator for longterm positive lifestyle changes among people affected by VHC?
A. Schweitzer
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020 Â
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Co-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trial
B. Eckhardt
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Simplified HCV treatment model in primary healthcare in the country of Georgia
E. DolmazashviliÂ
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Depist’c pharma an innovative outreach HCV screening project in pharmacy for drugs users and general population
A. Remy
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Videos
Challenges to Widespread PrEP in Europe: Social Aspects - Michael Meulbroek
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Challenges to Widespread PrEP in Europe: Clinical Aspects - Milosz Parczewski, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Overview of the current situation regarding PrEP and resistance - Daniel Kuritzkes, MD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
HCV Nextstrain - a phylogenetic tool to monitor HCV drug resistance and transmission - Anita Howe, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Hepatitis C Resistance: Pro Standpoint - Francesca Ceccherini - Silberstein, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Hepatitis C Resistance: Con Standpoint - JM Pawlotsky, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Treatment of Hepatitis B for HIV Clinicians - Anna Maria Geretti, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Management of the COVID 19 Pandemic in Europe - Physiopathology and treatment - Xavier Lescure, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Management of the COVID 19 Pandemic in Europe: Diagnostics - Ravindra Gupta, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Resistance to Long-Acting Antivirals - Anne-Geneviève Marcelin, PharmD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Implementing First Day Treatment in Europe: Central and Eastern Perspective Milosz Parczewski, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020